---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-25-000278"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:13:50.039544+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Dexcom Q3 revenue $1.209B (+22% YoY); raises FY 2025 revenue guidance to $4.63-4.65B

## Summary
- GAAP EPS $0.70 vs $0.34 YoY; non-GAAP EPS $0.61 vs $0.45 YoY.
- U.S. revenue +21% YoY; international revenue +22% reported, +18% organic.
- GAAP operating margin 20.1% (480 bps improvement); non-GAAP operating margin 22.6%.
- Stelo surpassed $100M revenue in first 12 months; submitted Dexcom Smart Basal to FDA.
- Cash and marketable securities $3.32B; revolver undrawn.

## SEC filing metadata
- accession: 0001093557-25-000278
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355725000278/0001093557-25-000278-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355725000278/dxcm-20251030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-25-000278
- JSON: https://secwatch.observer/filing/0001093557-25-000278.json
- Plain text: https://secwatch.observer/filing/0001093557-25-000278.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.